What are the non‑lupus causes of low complement levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Non-Lupus Causes of Low Complement Levels

Low complement levels occur in hereditary complement deficiencies, hereditary angioedema, immune complex-mediated diseases beyond lupus, complement consumption states, and infections—particularly neisserial infections with terminal pathway defects.

Primary Complement Deficiencies

Classical Pathway Deficiencies

  • C1, C2, and C4 deficiencies present with recurrent bacterial respiratory tract infections (similar to antibody deficiency patterns) and can paradoxically cause autoimmune disease resembling lupus but are distinct genetic entities 1.
  • These deficiencies show absent C4 with zero CH50 but normal AH50, distinguishing them from lupus-related consumption 2.
  • Patients typically experience recurrent encapsulated bacterial infections due to impaired immune complex clearance 3.

Alternative Pathway Deficiencies

  • Properdin, Factor B, and Factor D deficiencies manifest with recurrent Neisseria meningitidis infections 3, 4.
  • Laboratory findings show normal CH50 with low or absent AH50 1.
  • Properdin deficiency is X-linked recessive, making it more common in males 3.

Terminal Pathway Deficiencies (C5-C9)

  • C5 through C9 deficiencies cause recurrent neisserial meningitis and disseminated gonococcal infections 1.
  • Laboratory pattern: both CH50 and AH50 are zero 1, 2.
  • These patients have intact opsonization but cannot form the membrane attack complex 3.

Regulatory Component Deficiencies

  • Factor H and Factor I deficiencies lead to uncontrolled complement consumption, presenting with membranoproliferative glomerulonephritis and hemolytic uremic syndrome 3, 4.
  • Laboratory shows low CH50 with normal or low AH50 due to ongoing consumption 1.

Hereditary Angioedema

  • C1-inhibitor deficiency (hereditary angioedema) presents with recurrent episodes of acute swelling affecting face, extremities, gastrointestinal tract, and potentially the airway 5.
  • Low C4 with normal C3 is the characteristic pattern, distinguishing it from lupus where both are typically low 2, 5.
  • This is an autosomal dominant condition, unlike most complement deficiencies which are autosomal recessive 3.
  • Diagnosis requires confirmatory testing for C1-inhibitor antigenic and functional levels 2, 5.

Mannose-Binding Lectin (MBL) Pathway Deficiencies

  • MBL deficiency predisposes to recurrent bacterial respiratory tract infections, though other host factors often contribute 1.
  • This deficiency is autosomal co-dominant 3.
  • Clinical significance varies widely; many individuals remain asymptomatic 4.

Immune Complex-Mediated Diseases (Non-Lupus)

  • Simultaneous low C3 and C4 indicate complement consumption from immune complex formation in various autoimmune conditions beyond lupus 2.
  • Other autoimmune diseases causing complement consumption include mixed cryoglobulinemia, serum sickness, and post-infectious glomerulonephritis 3.
  • The pattern mimics lupus but occurs in distinct clinical contexts 4.

Infections

  • Acute bacterial infections can cause transient complement consumption, particularly with overwhelming sepsis 3.
  • Subacute bacterial endocarditis classically causes low complement levels through immune complex formation 4.

Critical Specimen Handling Caveat

  • Complement proteins are highly labile and degrade rapidly when specimens are warmed; falsely low levels occur if blood is not immediately placed on ice or refrigerated after collection 2.
  • This is a common pitfall leading to misdiagnosis—always verify proper specimen handling before attributing clinical significance to low values 2.

Management Approach for Complement Deficiencies

  • No specific therapy exists for inherited complement deficiencies; management focuses on antibiotic prophylaxis and immunization for recurrent infections 1.
  • Consultation with immunology specialists experienced in complement disorders is recommended for optimal outcomes 1.
  • For hereditary angioedema specifically, C1-inhibitor replacement and targeted therapies are available 5.

References

Guideline

practice parameter for the diagnosis and management of primary immunodeficiency.

Journal of Allergy and Clinical Immunology, 2015

Guideline

Clinical Interpretation and Testing of Complement Proteins C3 and C4

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Clinical significance of complement deficiencies.

Annals of the New York Academy of Sciences, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.